EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis

Juan Sebastián Frías-Ordóñez iD, Sebastián Niño-Ramírez iD, Juan Camilo Pérez, Katherine Caita, José Darío Portillo-Miño iD, Arnoldo Riquelme Pérez iD, Lina Otero-Parra iD, Hernando Marulanda-Fernández iD, Elder Otero-Ramos iD, William Otero-Regino iD

Helicobacter · 2026-09 · 31 (5)

DOI: 10.1111/hel.70168 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Helicobacter, online erschienen am 13.10.2026. Verfasst von Juan Sebastián Frías-Ordóñez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Nacional de Colombia, Bogotá, Colombia. Hauptthemen laut MEDLINE: Gastritis, Helicobacter Infections, Stomach Neoplasms, Stomach. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) systems stratify gastric cancer (GC) risk according to the extent of gastric atrophy and intestinal metaplasia. However, the clinical significance of intermediate stages remains uncertain.

Objective

To evaluate the association between OLGA/OLGIM stages and GC, with particular focus on the potential role of intermediate stages as early histological risk markers.

Methods

A systematic review and meta‐analysis (PROSPERO CRD42024549931) was conducted according to PRISMA 2020 guidelines. Cohort, case–control, and cross‐sectional studies reporting GC incidence or prevalence according to OLGA and/or OLGIM stage were included. Methodological quality was assessed using the Newcastle‐Ottawa Scale and certainty of evidence using GRADE. Random‐effects models were used to calculate pooled odds ratios (OR) and risk ratios (RR).

Results

Twenty‐eight studies involving 23,390 patients were included. Methodological quality was high and certainty of evidence was moderate. Advanced OLGA III–IV and OLGIM III–IV stages were strongly associated with GC (OR 6.49 and 7.76; RR 13.26 and 4.34, respectively). Intermediate stages were also associated with GC in observational studies: OLGA II (OR 2.77; 95% CI 1.83–4.20; I 2 = 71%) and OLGIM II (OR 3.63; 95% CI 2.90–4.55; I 2 = 0%). However, prospective cohort studies did not demonstrate a statistically significant increase in future GC incidence for OLGA II (RR 1.20; 95% CI 0.85–1.69).

Conclusions

Intermediate OLGA and OLGIM stages may represent early histological markers associated with gastric carcinogenesis. Prospective studies are required to determine their predictive value and potential implications for surveillance strategies, particularly in high‐incidence populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastritisHelicobacter InfectionsStomach NeoplasmsStomachHumansMetaplasiaRisk Factors

Stichwörter der Autor:innen

Helicobacter pyloriOLGAOLGIMendoscopic surveillancegastric atrophygastric cancerintestinal metaplasiameta‐analysis

Autor:innen und Institutionen

  • Universidad Nacional de Colombia, Bogotá, Colombia.
  • Hospital Internacional de Colombia, Bucaramanga, Colombia.
  • Grupo Colombiano de Investigación en Helicobacter Pylori, Bogotá, Colombia.
  • Facultad de Medicina, Universidad CES, Medellín, Colombia.
  • Instituto Gastroclínico, Medellín, Colombia.
  • Grupo de Investigación en Ciencias de la Salud (GICIENSA), Faculty of Health Sciences, Medicine Program, Universidad de Nariño, Pasto, Colombia.

ORCID-Profile: Juan Sebastián Frías-Ordóñez, Sebastián Niño-Ramírez, José Darío Portillo-Miño, Arnoldo Riquelme Pérez, Lina Otero-Parra, Hernando Marulanda-Fernández, Elder Otero-Ramos, William Otero-Regino

Zitieren

APA

Frías-Ordóñez, J. S., Niño-Ramírez, S., Pérez, J. C., Caita, K., Portillo-Miño, J. D., Pérez, A. R., Otero-Parra, L., Marulanda-Fernández, H., Otero-Ramos, E., & Otero-Regino, W. (2026). Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis. Helicobacter, 31(5). https://doi.org/10.1111/hel.70168

Vancouver

Frías-Ordóñez JS, Niño-Ramírez S, Pérez JC, Caita K, Portillo-Miño JD, Pérez AR, et al. Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis. Helicobacter. 2026;31(5). doi:10.1111/hel.70168

BibTeX
@article{FrasOrdez2026,
  author = {Frías-Ordóñez, Juan Sebastián and Niño-Ramírez, Sebastián and Pérez, Juan Camilo and Caita, Katherine and Portillo-Miño, José Darío and Pérez, Arnoldo Riquelme and Otero-Parra, Lina and Marulanda-Fernández, Hernando and Otero-Ramos, Elder and Otero-Regino, William},
  title = {Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis},
  journal = {Helicobacter},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.1111/hel.70168}
}
Kostenlos starten →